跳至主要内容
临床试验/ACTRN12623001187639
ACTRN12623001187639招募中Unknown

Effect of Accelerated Pacing Rates on Exercise Tolerance, Quality of Life and Arrhythmia Burden in Patients with Evidence of Heart Failure with Preserved Ejection Fraction: The PACE-UP Randomised Controlled Trial

niversity of Adelaide0 个研究点目标入组 160 人开始时间: 2023年11月17日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Adults 18-80 years old with a pacemaker.
  • Preclinical or clinical heart failure with preserved ejection fraction according to the diagnostic criteria of the HFA of the ESC.
  • Sinus node dysfunction with intact AV node conduction or minimal RV pacing (<20%) and paced QRS <150ms.
  • Impaired AV node conduction with His bundle or left bundle branch area pacing, or biventricular pacing.
  • Subject is expected to remain available for follow-up visits.

排除标准

  • Left ventricular ejection fraction <45%.
  • Inability to participate in exercise testing due to musculoskeletal disease or other active diseases.
  • Myocardial infarction within the past 12 months.
  • Infiltrative cardiomyopathy.
  • Hypertrophic cardiomyopathy.
  • More than moderate valvular stenosis or regurgitation.
  • Aortic valve replacement in the past one year.
  • Significant primary pulmonary disease on home oxygen.
  • Uncontrolled hypertension as defined by BP >160/100 mmHg on two measurements >15 minutes apart.

研究者

发起方
niversity of Adelaide

相似试验